Steve Kyle

Steve Kyle has an extensive background in oncology sales, currently serving as a Hematology Clinical Account Specialist at Pharmacyclics, an AbbVie Company, since December 2019. Responsibilities include promoting Epkinly and Imbruvica to hematologists, oncologists, and bone marrow transplant physicians across Dallas, North LA, and East Texas. Prior roles include Senior Hematology Specialist at Amgen, Executive Clinical Oncology Specialist at AstraZeneca, and Regional Oncogenomic Liaison at Genomic Health, among others, showcasing a consistent focus on innovative treatments in hematology and oncology. Steve holds a Bachelor of Business Administration from the University of Houston.